The growing interest in potent weight management has led to considerable research into novel treatments. Lately , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist , has demonstrated positive results in medical trials, suggesting potential f